Delivery Order SPE2DB25D3012-SPE2DB25FWVSU
Award Date
2/25/25
Potential Completion Date
3/18/25
Potential Value
$2.3K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,343.59, is for the delivery of TEZSPIRE 210 MG/1.91 ML PEN 1.91ML, a pharmaceutical product. This is a firm fixed-price delivery order contract with a completion date of March 5, 2025. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp is...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,265.29, is for the delivery of TEZSPIRE 210 MG/1.91 ML PEN 1.91ML, a pharmaceutical product. This is a firm-fixed-price delivery order contract with a completion date of February 12, 2024. The contract was awarded on January 22, 2024, and does not have a set-aside designation, indicating open...
This federal contract award, valued at $2,265.29, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of TEZSPIRE 210 MG/1.91 ML PEN 1.91ML, a medical product, with an ultimate completion date of November 13, 2024. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA, valued at $999,999,999 and...
This is a federal contract award made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $2,343.59, is for the delivery of TEZSPIRE 210 MG/1.91 ML PEN 1.91ML, a medical product. The contract has an ultimate completion date of February 6, 2025 and is a firm fixed-price delivery order. The award is not designated as a set-aside contract. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,030.77, is for the delivery of TEZSPIRE 210 MG/1.91 ML PEN 1.91ML, a medical product, with a completion date of February 18, 2025. The contract is a Delivery Order with a Firm Fixed Price pricing type. This award is not associated with a set-aside designation. AmerisourceBergen Drug Corp holds a...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of TEZSPIRE 210 MG/1.91 ML PEN 1.91ML, a pharmaceutical product, with a ceiling value of $2,265.29. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of September 5, 2024. AmerisourceBergen Drug Corp is the prime contractor, and the contract is not set aside for any...
This is a federal contract award made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,343.59, is for the delivery of TEZSPIRE 210 MG/1.91 ML PEN 1.91ML, a medical product. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 held by AmerisourceBergen with the DLA Troop Support Medical, which provides a comprehensive range of...
This federal contract award, valued at $2,343.59, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The contract is for the delivery of TEZSPIRE 210 MG/1.91 ML PEN 1.91ML, a specialty medication, with a performance period ending on January 15, 2025. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999, which AmerisourceBergen holds with the DLA Troop Support Medical....
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $11,326.45, is for the supply of TEZSPIRE 210 MG/1.91 ML PEN 1.91ML, a specialty pharmaceutical product. The contract has a firm fixed-price pricing type and a period of performance through February 7, 2024. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,795.87, is for the delivery of TEZSPIRE 210 MG/1.91 ML PEN 1.91ML, a medical product. The contract is a Delivery Order with a Firm Fixed Price pricing type, and the ultimate completion date is February 28, 2024. There is no set-aside designation for this award. Amerisourcebergen Drug Corp is the...